FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 87 filers reported holding FORTRESS BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,889 | -76.4% | 44,400 | -55.4% | 0.00% | -100.0% |
| Q2 2023 | $54,698 | -39.9% | 99,450 | -10.4% | 0.00% | 0.0% |
| Q1 2023 | $90,979 | -10.8% | 110,950 | -28.7% | 0.00% | 0.0% |
| Q4 2022 | $101,951 | -99.9% | 155,650 | -50.6% | 0.00% | 0.0% |
| Q3 2022 | $135,135,000 | +103056.5% | 315,100 | +101.9% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | -39.9% | 156,100 | -2.8% | 0.00% | -50.0% |
| Q1 2022 | $218,000 | -48.9% | 160,550 | -6.0% | 0.00% | -50.0% |
| Q4 2021 | $427,000 | -22.4% | 170,813 | +0.0% | 0.00% | -20.0% |
| Q3 2021 | $550,000 | -7.1% | 170,763 | +3.0% | 0.01% | -28.6% |
| Q2 2021 | $592,000 | -0.7% | 165,763 | -1.8% | 0.01% | -12.5% |
| Q1 2021 | $596,000 | -3.6% | 168,763 | -7.1% | 0.01% | +14.3% |
| Q4 2020 | $618,000 | -99.9% | 181,713 | +4.4% | 0.01% | -46.2% |
| Q3 2020 | $703,000,000 | – | 174,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |